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Highlights  
 
x Upper body acceleration gait variables are sensitive to HDUO\3DUNLQVRQ¶VGLVHDVH  
x Upper body movements are mainly independent from spatiotemporal characteristics  
x Regression showed upper body movement was favorable to spatiotemporal 
information 
x Upper body variables should be measured with spatiotemporal characteristics  
x Pelvis acceleration variables are promising for the assessment of free-living gait  
 
Abstract 
 
Background: Changes in upper body (UB) motion during gait may be a marker of incipient pathology, 
intervention response and disease SURJUHVVLRQLQ3DUNLQVRQ¶VGLVHDVH3'), which if independent from 
the lower body motion, might provide an improved assessment of gait.  
Research question: This study aimed to test this hypothesis and establish whether variables calculated 
from accelerations measured on the UB are unique from spatiotemporal characteristics and can 
contribute to an improved classification of PD gait.  
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Methods: Data was obtained from 70 people with PD (69.2±9.9 y.o., UPDRS III: 36.9±12.3) and 64 
age-matched controls (71.6±6.8 y.o.). Spatiotemporal characteristics were measured using a pressure 
sensitive mat (GAITRite). Head and pelvis accelerations were synchronously measured with wearable 
inertial sensors (Opal, APDM)3HDUVRQ¶VSURGXFW-moment correlations were calculated between 49 
selected variables from UB accelerations (representing magnitude, smoothness, regularity, symmetry 
and attenuation) and 16 traditional spatiotemporal characteristics (representing pace, variability, 
rhythm, asymmetry and postural control). Univariate and multivariate regression analysis was used to 
test the variables ability to classify PD gait.  
Results: The variables were mostly unique from each other (67% of variables recorded an r < 0.3). 
Univariate and multivariate analysis showed that UB variables were moderately better at classifying 
PD gait than the spatiotemporal characteristics (Univariate: 0.70 to 0.81, Multivariate: 0.88 to 0.91 
AUC). 
Significance: This study showed for the first time that, if aiming at objective and optimal sensitive 
biomarkers for PD, UB variables should be measured in conjunction with spatiotemporal 
characteristics to obtain a more holistic assessment of PD gait for use in a clinical or free-living 
environment.  
 
Keywords: Gait analysis Accelerometers Harmonic ratio Balance Head and pelvis Human movement 
 
Introduction 
1HXURGHJHQHUDWLYHGLVHDVHVVXFKDV3DUNLQVRQ¶VGLVHDVH3'impair the ability to walk safely and 
efficiently [1]. Consequently, gait has been introduced as a biomarker to identify incipient pathology, 
contribute towards diagnostic algorithms, and quantify disease progression and response to 
intervention [2]. A majority of research and clinical analysis of PD gait has been performed in 
research laboratory settings and is primarily focused on movement of the lower limbs, especially end 
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point trajectories of the feet which are expressed by standard spatiotemporal measures (such as step 
length and cadence). The emergence of small, lightweight inertial measurement units (IMUs) has 
facilitated measurement of upper body motion, which is known to be impaired in PD due to increased 
axial rigidity, asymmetrical arm swing and flexed posture. [3,4]. Therefore, its measurement may be 
further indicative of a reduced postural control and highlight disease specific impairments. 
Consequently, new gait variables calculated using IMUs have been developed and are proposed to 
describe magnitude, smoothness, attenuation, regularity and symmetry [5]. If these upper body 
variables highlight different aspects of motion, they may capture important clinical features of PD gait 
that are not already described by spatiotemporal measurements and are more indicative of impaired 
control [6,7]. Being able to measure gait using body worn sensors such as the IMUs might be more 
easily applied to clinics and free-living environments [8,9]. 
Although certain upper body variables can indicate a reduced quality of gait in PD [10±12], previous 
studies have typically assessed few variables using small sample sizes or focused upon other 
promising measures such as arm swing (not considered here due to a singular focus on the WUXQN¶V 
movements) [5]. Furthermore, as movements of the upper and lower body are rarely assessed in 
conjunction with each other [7], it is unknown whether upper body movements describe unique 
information or are merely a reflection of impaired lower body gait mechanics. If measuring 
movements of the upper body in PD can provide unique information, their inclusion to current gait 
models may improve objective measurement of gait impairments symptomatic of PD. It is 
hypothesised that because the aforementioned symptoms are specific to the upper body, its 
measurement will better characterise PD gait. Our aims in this study were therefore, to establish 
whether: i) upper body accelerations during gait are merely a reflection of lower body mechanics and 
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are correlated with spatiotemporal characteristics; and ii) if upper body accelerations can discriminate 
between people with PD and age-matched controls independently and in combination with   standard 
spatiotemporal characteristics with the potential to better characterise PD gait. 
Methods 
Subjects 
Seventy participants with early stage PD (Age: 69.2 ± 9.9 yr, 23 females, Height: 1.68 ± 0.01 cm, 
Mass: 76.94 ± 16.16 kg, UPDRS III: 36.9 ± 12.3) and 64 age-matched controls (Age: 71.6 ± 6.8 yr, 
29 females, Height 1.70 ± 0.10 cm, Mass: 80.12 ± 13.20 kg) were recruited into ICICLE-GAIT, a 
collaborative study within ICICLE-PD, an incident cohort study (Incidence of Cognitive Impairment 
in Cohorts with Longitudinal Evaluation ± 3DUNLQVRQ¶VGLVHDVH within 4 months of diagnosis. 
Participants were excluded from ICICLE-GAIT if they had any neurological (other than PD), 
orthopedic, or cardiothoracic conditions that may have markedly affected their walking or safety 
during the testing sessions. People with PD had to be diagnosed with idiopathic PD according to the 
8.3DUNLQVRQ¶V'LVHDVH%UDLQ%DQNFULWHULDDQGZere excluded if they presented with significant 
PHPRU\LPSDLUPHQW0LQL0HQWDO6WDWH([DP006([13]), dementia with Lewy bodies, drug 
LQGXFHGSDUNLQVRQLVP³YDVFXODU´SDUNLQVRQLVPSURJUHVVLYHVXpranuclear palsy, multiple system 
atrophy, corticobasal degeneration or poor command of English. None of the participants 
demonstrated severe tremor or dyskinesia. This study was conducted according to the Declaration of 
Helsinki and had ethical approval from the Newcastle and North Tyneside research ethics committee. 
All participants signed an informed consent form. 
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Measurement protocol 
All participants were tested on medication and walked at their preferred pace for two minutes around 
a 25 m circuit containing a 7 m long pressure sensitive electronic walkway (Platinum model 
GAITRite, software version 4.5, CIR systems, United States of America) [14]. Accelerations were 
measured using two IMUs (128 +]2SDO$3'0,QF3RUWODQG2586$ located at 5th lumbar 
vertebra, to represent movement of WKHSHOYLVDQGXSRQWKHEDFNRIWKHKHDG7KHVHQVRU¶VX axis 
pointed downwards representing the vertical direction (V), the Y axis pointed to the left representing 
the medio-lateral direction (ML) and the Z axis pointed backwards representing the anterior-posterior 
direction (AP). The instrumented walkway and the IMUs were synchronised (±1 sample) using a 
custom-made cable and the data was collected at 128 Hz using the same A/D converter. The 
acceleration data was segmented based upon the timing values obtained from the instrumented 
walkway meaning only straight line walking while in contact with the walkway was analysed.  
Variables  
Sixteen clinically relevant spatiotemporal variables were selected a priori according to a five-domain 
(pace, rhythm, variability, asymmetry and postural control) model of gait developed in older adults 
and validated in people with PD [2]. 
A broad range of upper body acceleration variables were selected for their applicability to be 
calculated in a clinical environment (e.g. using a limited enclosed space) and their ability to describe 
different domains of movement. Acceleration VLJQDOVZHUHUHDOLJQHGWRWKHHDUWK¶VJUDYLWDWLRQDO
constant [15,16], and a low-pass Butterworth filter with a cut-off frequency of 20 Hz was applied 
using MATLAB (version 8.4.0, R2014b) [7]. All variables were calculated on a single stride basis 
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except the autocorrelation variables (collected during each pass of the GAITRite mat). Each variable 
was calculated in the AP, ML and V direction. Upper body acceleration variables were grouped into 
five domains: Magnitude, represented from the acceleration RMS (RMS) [15,17]; Smoothness, 
represented by jerk RMS (jerk) [18,19] and the jerk ratio [20]; Attenuation, represented by the 
coefficient of attenuation (CoA) [17]; Regularity, represented by the step and stride output from 
calculating the unbiased autocorrelation [21]; and Symmetry, represented by both the symmetry 
output from the autocorrelation (Auto sym) [21] and the harmonic ratio (HR) [12]. 
Statistical analysis 
Group means and standard deviations of all variables were calculated to provide reference values for 
each group. To answer whether the upper body accelerations were correlated with the spatiotemporal 
characteristics (aim 1), 3HDUVRQ¶VFRUUHODWLRQs were calculated. Following checking for normality and 
ensuring a normal distribution in all parameters, to address the second aim, a univariate analysis 
(receiver operator characteristic (ROC) curve) was first used to quantify how well each upper body 
acceleration variable could discriminate between people with PD and age-matched controls. Variables 
with AUC below 0.6 were removed to refine the models, to avoid multicolinearity and overfitting 
each model in the subsequent multivariate analysis. A multivariate analysis (binary logistic regression 
followed by ROC) was then performed using variables from the head, pelvis and the spatiotemporal 
model independently and in combination with each other. For the independent analysis, participant 
descriptors (e.g. age, sex, height and mass) were controlled for by force entering them into the 
analysis as an initial block. Block two was performed in a forward stepwise fashion. To test whether 
additional classification could be achieved using the acceleration variables in combination to the 
VSDWLRWHPSRUDOPRGHO¶VYDULDEOHVDWKree-block model was also used. For this 3 block analysis, the 
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spatiotemporal variables were first entered in block two (forward stepwise) and the upper body 
acceleration variables were then subsequently added in a forward stepwise fashion in the third block 
to determine if they could add any significant additional classification.  
Results 
Table 1 shows all variable values and their corresponding univariate AUC values. 
Most variables only mildly correlated with the variables within the spatiotemporal model (<0.3: 59% 
and 67%, >0.3 and <0.5: 20% and 19%, >0.5 and < 0.7: 15% and 9%, >0.7: 6% and 6% for the 
control and PD group, respectively) (figure 1). Spatiotemporal variables describing Pace were 
correlated with all upper body domains, although strong correlations were only seen between with 
step regularity. Bar a few exceptions, the absolute difference between the PD and control group r 
values was similar between both groups therefore highlighting similar coupling between upper body 
accelerations and lower body spatiotemporal characteristics in both groups. 
 
The univariate ROC curve analysis showed that 62% (10 out of 16) of the spatiotemporal variables 
and 75% (37 out of 49) of the upper body variables significantly discriminated between the two 
groups (AUC > 0.6; p <  0.05). The single best discriminating variable of PD gait was step regularity 
obtained from calculating the autocorrelation from ML pelvis acceleration (AUC = 0.81). The highest 
AUC for the spatiotemporal values was swing time variability (AUC = 0.70). The top ten classifiers 
for the spatiotemporal model and the upper body acceleration variables are shown in figure 2. Figure 
3, shows the spatiotemporal model [2] and the conceptual acceleration based models following the 
univariate variable reduction. Each model shows the deviation of the Z score as calculated using the 
age matched controls mean and standard deviation values as a reference.  
 
The AUC values and variables in the multivariate models are shown in Table 2 for both the two and 
three block methods. The force entered patient demographic information in Block 1 recorded a AUC 
of 0.729 (CI95%: 0.64-0.81). When the gait variables were then entered in a forward stepwise fashion, 
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DOOPRGHO¶V$8&VZHre greater than 0.88, confirming the importance of looking at a gait in a multi-
facet way when using it as a biomarker in PD. With the two block method there was only a difference 
of 0.025 AUC between the poorest (spatiotemporal model, AUC: 0.88, CI95%: 0.83-0.94) and best 
(head model, AUC: 0.91, CI95%: 0.86-0.96) model. The 3 block analysis was performed to discover if 
measuring upper body movement provided additional classification ability. Therefore, the 
spatiotemporal variables were entered in block 2 (forward stepwise) and the acceleration based 
variables where subsequently entered in block 3 (also forward stepwise). This additional block 
achieved a significant improvement to the spatiotemporal model, however, the AUC only increased 
by 0.01, 0.02 and 0.02 for the head model, pelvis model and the combined information from the head 
and pelvis model, respectively.  
 
Discussion 
This study showed that, not all information about impaired PD gait can be captured through 
measuring spatiotemporal information and as such upper body accelerations provide novel 
information about gait. For the purpose of discriminating between the two groups, this information 
was as good, if not better, than standard spatiotemporal gait characteristics. The upper body is 
therefore not merely a passenger unit during gait and its motion may be a useful biomarker for PD. 
When combined with the spatiotemporal information, upper body acceleration variables contributed 
to a better description PD gait, however, the improved discrimination ability was negligible.  
Surprisingly, none of the upper body variables were highly correlated with the variables within the 
postural control domain within the spatiotemporal model, despite often being defined as a direct 
measure [5]. This lack of correlation may suggest that the different variables measure different 
aspects of postural control. Previous studies that focused on the movement of the head during gait for 
people with PD concluded that a lack of correlation between acceleration based gait stability measures 
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and lower body mechanics suggest they are distinct and can provide separate targets for therapy [10]. 
The fact that unique and favorable information was obtained through measuring upper body 
accelerations supports the idea that new and useful information is gained relative to just 
spatiotemporal characteristics and that a multidimensional analysis of gait may help to further 
understand the complexity of gait impairment and progression in PD [22]. Therefore, this 
uncorrelated and additional information supports that this information should be assessed in 
conjunction and potentially provide separate targets for therapy.  
Regarding the variables that did correlate, such as the variables within the regularity and pace 
domains, the acceleration regularity variables achieved higher AUC variables than the pace domain 
spatiotemporal variables (one exception). As pace provides very useful information about disease 
progression [23], the potential of obtaining a proxy measure outside a controlled environment may be 
advantageous. Previous work stated that the relationship between walking speed, regularity and 
symmetry needs further analysis to discover if they are the same or separate constructs of gait [21]. 
Although this was not the focus of the investigation, the fact that regularity and symmetry variables 
correlated with the variables from the pace domain but were better capable to classify PD gait, opens 
the opportunity for acceleration based measures to replace or be combined with more traditionally 
used variables within multivariate gait models. One example where this may be beneficial is within 
the recent emphasis of trying to obtain relevant gait measures from participants in a free living 
environment [8,24]. For example, when recently attempting to replicate the spatiotemporal model 
using a single accelerometer located on the pelvis [8], step width and step width variability could not 
be calculated and the postural control domain in the model could not be replicated. Future research is 
therefore warranted to determine if the accelerations variables shown to be effective to characterise 
AC
CE
PT
ED
 M
AN
US
CR
IPT
PD gait in the current investigation can be reliably obtained in a variety of environments and add to 
the free-living spatiotemporal model as a new representation of the postural control domain. 
Negligible differences in the ability to classify the PD based on their gait were found between the 
spatiotemporal model and those from the head or pelvis accelerations models. Therefore, if physical 
and economical resources are limited, models created from upper body accelerations could equally be 
used to classify PD gait. For this purpose, a sensor placed upon the pelvis may be the most applicable 
due to its methodically preferable location and ability to detect stride timing information in a variety 
of environments [16,25]. Furthermore if placed at the pelvis, the variables in the current investigations 
can potentially be combined with further variables such as stability measures [26] and turning 
characteristics [27], which were not included in this study due to methodological limitations. 
However prior to this, each variable needs to have their reliability assessed and to determine their 
efficacy to detect longitudinal and intervention outcomes.  
The reported results showed that movements and multiple variables from the upper body can classify 
PD gait and as such this study represents an important step toward their adoption as useful biomarkers 
in the clinic or free-living environment. Nonetheless, discovering which of these variables (or even 
variables from other movements such as those calculated from arm swing movements) are sensitive 
and specific to the underlying disease process in PD [18], is a next essential step. However to achieve 
this step, longitudinal assessments are needed to examine how well upper body accelerations can 
track changes to gait due to disease progression and response to intervention [5,18], particularly in 
free-living and clinical settings where it is often impractical to measure gait using traditional methods 
of three-dimensional motion capture or instrumented walkways. 
Conclusion 
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Most upper body acceleration variables provided additional and unique information about PD gait 
with respect to a traditional spatiotemporal gait model. The current results show promise for using 
acceleration based variables to highlight movements symptomatic of PD gait either alone or in 
addition to spatiotemporal characteristics. Until it is known exactly which variables are best for the 
desired purpose of using gait as a biomarker and the causality of the connection between the upper 
and lower body during gait is better understood, we recommend acceleration variables should still be 
assessed in conjunction to spatiotemporal variables in an attempt to record a holistic characterisation 
of PD gait. The results of this investigation warrants continued research to refine the best 
characterisation of PD gait using multiple techniques and different domains of gait in order to provide 
a more objective assessment of gait and improve the observation of people with PD in a clinical, or 
potentially, free-living environment.  
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Table 1 mean, standard deviation and univariate AUC values of all spatiotemporal and upper 
body acceleration variables for people with PD and controls  
Variable 
type Domains Variable 
Control 
Mean (SD) 
PD 
Mean (SD) AUC 
Sp
at
io
te
m
po
ra
l c
ha
ra
ct
er
ist
ic
s  
Pace 
 Step velocity 1.28 ± 0.19 1.13 ± 0.22 0.687 
 Step Length 0.68 ± 0.08 0.61 ± 0.11 0.674 
 Swing  time SD 13.68 ± 3.86 18.08 ± 8.27 0.698 
Variability 
 Step time SD 14.94 ± 5.54 19.23 ± 9.3 0.667 
 Stance  time SD 23.03 ± 9.66 27.11 ± 12.6 0.59 
 Step velocity SD 0.05 ± 0.01 0.05 ± 0.01 0.556 
 Step length SD 0.02 ± 0 0.02 ± 0.01 0.662 
Rhythm 
 Step time 0.53 ± 0.04 0.54 ± 0.04 0.566 
 Swing time 0.38 ± 0.03 0.38 ± 0.03 0.51 
 Stance time 0.68 ± 0.06 0.71 ± 0.06 0.595 
Asymmetry 
 Step time asymmetry 12.6 ± 11.14 20.42 ± 16.76 0.64 
 Swing time asymmetry 8.19 ± 8.3 15.01 ± 11.74 0.673 
 Stance time asymmetry 8.62 ± 8.86 15.37 ± 11.94 0.688 
Postural control 
 Step length asymmetry 0.01 ± 0.01 0.02 ± 0.02 0.65 
 Step width 0.09 ± 0.02 0.09 ± 0.03 0.514 
 Step width SD 0.02 ± 0 0.02 ± 0 0.678 
U
pp
er
 b
od
y 
ac
ce
le
ra
tio
n
s  
Magnitude 
(ms-2) 
H
ea
d 
RMS (AP) 0.66 ± 0.16 0.69 ± 0.25 0.505 
RMS (ML) 0.86 ± 0.24 0.82 ± 0.27 0.547 
RMS (V) 1.75 ± 0.55 1.4 ± 0.47 0.696 
Pe
lv
is 
RMS (AP) 1.12 ± 0.31 0.92 ± 0.33 0.689 
RMS (ML) 1.03 ± 0.37 0.83 ± 0.3 0.655 
RMS (V) 1.82 ± 0.56 1.51 ± 0.52 0.671 
Smoothness 
(Jerk = ms-2) 
(Jerk ratio = dB) 
H
ea
d 
Jerk (AP) 17.27 ± 6.39 19.51 ± 7.26 0.592 
Jerk (ML) 16.07 ± 5.16 16.84 ± 6.02 0.532 
Jerk (V) 47.01 ± 18.95 39.66 ± 14.05 0.609 
Jerk ratio (AP) -3.12 ± 1.1 -2.18 ± 1.35 0.727 
Jerk ratio (ML) -3.26 ± 1.07 -2.57 ± 1.07 0.668 
Pe
lv
is 
Jerk (AP) 46.38 ± 20.81 39.23 ± 20.64 0.625 
Jerk (ML) 43.19 ± 17.54 36.6 ± 14.78 0.615 
Jerk (V) 62.48 ± 29 52.76 ± 23.38 0.604 
Jerk ratio (AP) -0.92 ± 0.77 -0.97 ± 0.66 0.53 
Jerk ratio (ML) -1.13 ± 0.76 -1.06 ± 1.05 0.515 
Regularity H
ea
d 
Step (AP) 0.33 ± 0.2 0.28 ± 0.15 0.61 
Step (ML) -0.55 ± 0.1 -0.43 ± 0.12 0.757 
Step (V) 0.6 ± 0.12 0.46 ± 0.14 0.763 
Stride (AP) 0.47 ± 0.12 0.39 ± 0.14 0.659 
Stride (ML) 0.58 ± 0.1 0.47 ± 0.13 0.729 
Stride (V) 0.6 ± 0.12 0.48 ± 0.15 0.732 
Pe
lv
is 
Step (AP) 0.51 ± 0.12 0.38 ± 0.13 0.76 
Step (ML) -0.42 ± 0.13 -0.26 ± 0.11 0.81 
Step (V) 0.57 ± 0.12 0.44 ± 0.14 0.747 
Stride (AP) 0.57 ± 0.12 0.45 ± 0.14 0.741 
Stride (ML) 0.49 ± 0.13 0.36 ± 0.14 0.739 
Stride (V) 0.59 ± 0.12 0.47 ± 0.14 0.724 
Symmetry H
ea
d 
Auto symmetry (AP) 0.46 ± 0.27 0.4 ± 0.18 0.629 
Auto symmetry (ML) -0.64 ± 0.11 -0.54 ± 0.15 0.748 
Auto symmetry (V) 0.67 ± 0.11 0.55 ± 0.13 0.776 
HR (AP) 1.19 ± 0.33 1.18 ± 0.33 0.513 
HR (ML) 2.17 ± 0.6 1.93 ± 0.56 0.621 
HR (V) 2.49 ± 0.63 1.96 ± 0.51 0.739 
Pe
lv
is 
Auto symmetry (AP) 0.61 ± 0.12 0.49 ± 0.13 0.749 
Auto symmetry (ML) -0.59 ± 0.14 -0.44 ± 0.15 0.77 
Auto symmetry (V) 0.66 ± 0.11 0.54 ± 0.13 0.749 
HR (AP) 1.96 ± 0.54 1.54 ± 0.37 0.724 
HR (ML) 1.63 ± 0.5 1.27 ± 0.4 0.729 
HR (V) 2.36 ± 0.63 1.89 ± 0.5 0.72 
Attenuation 
(%) 
H
ea
d 
&
 
Pe
lv
is 
CoA (AP) 26.82 ± 15.76 12.43 ± 23.65 0.702 
CoA (ML) 5.86 ± 22.86 -5.35 ± 27.1 0.62 
CoA (V) 2.82 ± 6.13 4.37 ± 8.25 0.531 
 
a. AP = anterior-posterior. ML = medio-lateral. V = vertical 
b. SD = standard deviation 
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 Table 2. Results of the two block and three block multivariate analysis including area under 
the curve (AUC and 95 CI) values and list of the variables included in the model. 
a. AP = anterior-posterior. ML = medio-lateral. V = vertical 
b. SD = standard deviation 
Block number  Variables 
added AUC 
95% CI 
Variables in the model  Lower 
Bound 
Upper 
Bound 
Two block method 
Block 1 
(force entered) 
Demographic 
information 0.729 0.644 0.814 
Age 
Sex 
Height 
Mass 
Block 2 
(stepwise entered) 
Spatiotemporal  0.887 0.83 0.943 
Step length 
Swing time SD 
Step width SD 
Head 0.912 0.863 0.961 
Jerk RMS (V) 
Jerk ratio (ML) 
Step regularity (ML) 
Step regularity (V) 
Auto symmetry (AP) 
Pelvis 0.896 0.842 0.951 
Step regularity (ML) 
Stride regularity (AP) 
Three block method 
Block 1 
(force entered) 
Demographic 
information 0.729 0.644 0.814 
Age 
Sex 
Height 
Mass 
Block 2 
(stepwise entered) 
Spatiotemporal 
model 0.887 0.83 0.943 
Step length 
Swing time SD 
Step width SD 
Block 3 
(stepwise entered) 
Head 0.898 0.846 0.95 Jerk ratio  (AP/V) 
Pelvis 0.904 0.853 0.955 Step regularity  (ML) 
Head & Pelvis 0.904 0.853 0.955 Step regularity  (ML PV) 
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a* indicates a significant correlation at the 0.05 significance level 
b AP = anterior-posterior. ML = medio-lateral. V = vertical 
c SD = standard deviation Asy = asymmetry  
 
)LJXUH+HDWPDSGLVSOD\LQJWKH3HDUVRQ¶VSURGXFW-moment correlation coefficients (r) 
between the variables representing spatiotemporal and upper body acceleration domains for 
both the PD (Red) and control group (Blue). 
 
 
 
 
 
 
 
 
 
 
r (PD) 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 
r (controls) 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 
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Figure 2. ROC for the top ten classifiers from the spatiotemporal model and the top ten from the 
upper body acceleration variables. 
 
 
Upper body acceleration 
Spatiotemporal characteristics   
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Figure 3, Radar plot illustrating 
each variable from the 
spatiotemporal, head and the 
pelvis model. The central line 
represents the control data. 
Deviation from zero along the X 
axis radiating from the center of 
the plot represents how many 
standard deviations (based upon 
the control means and standard 
deviations) the PD differ from the 
controls. 
Head  
Pelvis 
Spatiotemporal  
a. AP = anterior-posterior. ML = medio-
lateral. V = vertical 
b. SD = standard deviation Asy = 
asymmetry 
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